opioids
Insys Therapeutics founder John Kapoor found guilty of bribing doctors
May 3, 2019Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma
The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …
Former pharma wholesaler execs face criminal charges over opioid crisis
April 24, 2019Research and Development Litigation, RDC, Rochester Drug Cooperative, opioid crisis, opioids
Laurence Doud III, the former CEO of New York-based Rochester Drug Co-operative (RDC) – one of the largest drug distributors …
Opioid crisis cost US government nearly $38 billion in lost taxes
April 11, 2019Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue
The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …
Indivior shares fall by 70% after allegations of fraud
April 10, 2019Research and Development Virginia, indivior, opioid crisis, opioids, suboxone
Shares in London-listed Indivior plummeted this morning after US Federal prosecutors said the British drugmaker had deceived doctors as to …
Sacklers file motion to throw lawsuit out of court
April 5, 2019Medical Communications Massachusetts, OxyContin, Purdue Pharma, opioid crisis, opioids, sackler
Members of the Sackler family have asked a judge to throw a lawsuit – filed by Massachusetts attorney general Maura …
Sacklers fraudulently transferred funds to dodge litigation, lawsuit says
March 29, 2019Medical Communications Litigation, New York, OxyContin, Purdue Pharma, Sackelr, opioids
New York state prosecutors have filed a lawsuit against members of the Sackler family, alleging the Purdue Pharma controllers fraudulently …
Specialists petition FDA over opioid approval process
March 22, 2019Medical Communications FDA, approval process, opioid crisis, opioids, painkillers
FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …
NICE to set out new opioid prescription guidelines for GPs
March 18, 2019Sales and Marketing GPs, NICE, addiction, addictive drugs, opioids, prescription drugs, withdrawal
NICE is set to develop new guidelines for GPs and healthcare professionals setting out rules for doctors regarding opioids and …
Purdue Pharma vow not to profit from fast tracked opioid overdose antidote
March 18, 2019Sales and Marketing FDA, OxyContin, Purdue Pharma, nalmefene hydrochloride, opioids
The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection. However, …
Reformulated OxyContin led to spike in Hepatitis C infections
February 5, 2019Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids
Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …
Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”
January 31, 2019Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids
OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …
Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug
January 29, 2019Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids
Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …
Head of opioid advisory panel criticises FDA for complacency in ongoing crisis
January 28, 2019Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma
The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone
December 12, 2018Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics
December 11, 2018Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o
A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …
Latest content
